The enhancement of apoptosis by combined with proteasome inhibitor and DNA synthetic inhibitor in oral cancer |
Lee, Young-Hee
(Department of Oral biochemistry, School of Dentistry and Institute of Oral-bio Science, Chonbuk National University)
Jung, Ji-Eun (Department of Oral biochemistry, School of Dentistry and Institute of Oral-bio Science, Chonbuk National University) Lee, Jung-Chang (Department of Oral biochemistry, School of Dentistry and Institute of Oral-bio Science, Chonbuk National University) Moon, Hyun-Ju (Department of Oral biochemistry, School of Dentistry and Institute of Oral-bio Science, Chonbuk National University) Lee, Nan-Hee (Department of Oral biochemistry, School of Dentistry and Institute of Oral-bio Science, Chonbuk National University) Jhee, Eun-Jung (Department of Oral biochemistry, School of Dentistry and Institute of Oral-bio Science, Chonbuk National University) Yi, Ho-Keun (Department of Oral biochemistry, School of Dentistry and Institute of Oral-bio Science, Chonbuk National University) |
1 | Adams, J.: The proteasome: structure, function, and role in the cell. Cancer Treatment Rev. 29:3-9, 2003 |
2 | Cusack, J. C. Jr., Liu, R., Houston, M., Abendroth, K., Elliott, P. J., Adams, J., Baldwin, A. S. Jr.: Enhanced chemosensitivity to CPT-11 with proteasome inhibitor PS-341: implications for systemic nuclear factor-kappaB inhibition. Cancer Res. 61:3535-3540, 2001 |
3 | Omura, S., Matsuzakim K., Fujimoto, T., Kosuge, K., Furuya, T., Fujita, S., Nakagawa, A.: Structure of lactacystin, a new microbial metabolite which induces differentiation of neuroblastoma cells. J Antibiot. 44:117-118, 1991 DOI |
4 | Samuels-Lev, Y., O'Connor, D.J., Bergamaschi, D., Trigiante, G., Hsieh, J.K., Zhong, S., Campargue, I., Naumovski, L., Crook, T., Lu, X.: ASPP proteins specifically stimulate the apoptotic function of p53. Mol Cell. 8:781-794, 2001 DOI ScienceOn |
5 | Sun, Y.: Targeting E3 ubiquitin ligases for cancer therapy. Cancer Biol Ther. 2:623-629, 2003 |
6 | Aghajanian, C., Soignet, S., Dizon, D.S., Pien, C.S., Adams, J., Elliott, P.J., Sabbatini, P., Miller, V., Hensley, M.L., Pezzulli, S., Canales, C., Daud, A., Spriggs, D.R.: A phase I trial of the novel proteasome inhibitor PS341 in advanced solid tumor malignancies. Clin Cancer Res. 8:2505-2511, 2002 |
7 | Hideshima, T., Richardson, P., Chauhan, D., Palombella, V.J., Elliott, P.J., Adams, J., Anderson, K.C.: The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells. Cancer Res. 61:3071-3076, 2001 |
8 | Frankel, A., Man, S., Elliott, P., Adams, J., Kerbel, R.S.: Lack of multicellular drug resistance observed in human ovarian and prostate carcinoma treated with the proteasome inhibitor PS-341. Clin Cancer Res. 6:3719-3728, 2000 |
9 | Jeremias, I., Kupatt, C., Baumann, B., Herr, I., Wirth, T., Debatin, K.M.: Inhibition of nuclear factor kappaB activation attenuates apoptosis resistance in lymphoid cells. Blood. 91:4624-4631, 1998 |
10 | Adams, J., Palombella, V.J., Sausville, E.A., Johnson, J., Destree, A., Lazarus, D.D., Maas, J., Pien, C.S., Prakash, S., Elliott, P. J.: Proteasome inhibitors: a novel class of potent and effective antitumor agents. Cancer Res. 59:2615-2622, 1999 |
11 | Banerjee, D., Liefshitz, A.: Potential of the proteasomal inhibitor MG-132 as an anticancer agent, alone and in combination. Anticancer Res. 21:3941-3947, 2001 |
12 | Adachi, N., Suzuki, H., Iiizumi, S., Koyama, H.: Hypersensitivity of nonhomologous DNA end-joining mutants to VP-16 and ICRF-193: implications for the repair of topoisomerase II mediated DNA damage. J Biol Chem. 278:35897-35902, 2003 DOI ScienceOn |
13 | Lonial, S., Waller, E. K., Richardson, P. G., Jagannath, S., Orlowski, R. Z., Giver, C. R., Jaye, D. L., Francis, D., Giusti, S., Torre, C., Barlogie, B., Berenson, J. R., Singhal, S., Schenkein, D. P., Esseltine, D.L., Anderson, J., Xiao, H., Heffner, L.T., Anderson, K. C.: Risk factors and kinetics of thrombocytopenia associated with bortezomib for relapsed, refractory multiple myeloma. Blood. 106:3777-3784, 2005 DOI ScienceOn |
14 | Pickart, C.M.: Mechanisms underlying ubiquitination. Annu Rev Biochem. 70:503-533, 2001 DOI ScienceOn |
15 | Van de Loosdrecht, A. A., Nennie, E., Ossenkoppele, G. J., Beelen, R. H. J., Lngenhuijsen, M. M. A. C.: Cell mediated cytotoxicity against U937 cells by human monocytes and macrophages in modified colorimetric MTT assay. J Immunol Methods. 141:15-22, 1991 DOI ScienceOn |
16 | Wojcik, C.: Proteasomes in apoptosis: Villains or guardians? Cell Mol Life Sci. 56:908-917, 1999 DOI |
17 | An, W. G., Hwang, S.G., Trepel, J.B., Blagosklonny, M.V.: Protease inhibitor-induced apoptosis: accumulation of wt p53, p21WAF1/CIP1, and induction of apoptosis are independent markers of proteasome inhibition. Leukemia. 14:1276-1283, 2000 DOI |
18 | Ciechanover, A.: The ubiquitin-proteasome pathway. Cell 79:13-21, 1994 DOI ScienceOn |
19 | LeBlanc, R., Catley, L.P., Hideshima, T., Lentzsch, S., Mitsiades, C.S., Mitsiades, N., Neuberg, D., Goloubeva, O., Pien, C.S., Adams, J., Gupta, D., Richardson, P.G., Munshi, NC., Anderson, K.C.: Proteasome inhibitor PS-341 inhibits human myeloma cell growth in vivo and prolongs survival in a murine model. Cancer Res. 62:4996-5000, 2002 |
20 | Licitra, L., Grandi, C., Prott, F.J., Schornagel, J.H., Bruzzi, P., Molinari, R.: Major and minor salivary glands tumours. Crit Rev Oncol Hematol. 45:215-225, 2003 DOI ScienceOn |
21 | Roccaro, A. M., Hideshima, T., Raje, N., Kumar, S., Ishitsuka, K., Yasui, H., Shiraishi, N., Ribatti, D., Nico, B., Vacca, A., Dammacco, F., Richardson, P.G., Anderson, K.C.: Bortezomib mediates antiangiogenesis in multiple myeloma via direct and indirect effects on endothelial cells. Cancer Res. 66:184-191, 2006 DOI ScienceOn |
22 | Shah, S.A., Potter, M.W., McDade, T.P., Ricciardi, R., Perugini, R. A., Elliott, P. J., Adams, J., Callery, M. P.: 26S proteasome inhibition induces apoptosis and limits growth of human pancreatic cancer. J Cell Biochem. 82:110-122, 2001 DOI ScienceOn |
23 | Bross, P.F., Kane, R., Farrell, A.T., Abraham, S., Benson, K., Brower, M.E., Bradley, S., Gobburu, J.V., Goheer, A., Lee, S.L., Leighton, J., Liang, C.Y., Lostritto, R.T., McGuinn, W.D., Morse, D.E., Rahman, A., Rosario, L.A., Verbois, S.L., Williams, G., Wang, Y.C., Pazdur, R.: Approval summary for bortezomib for injection in the treatment of multiple myeloma. Clin Cancer Res. 10:3954-3964, 2004 DOI ScienceOn |
![]() |